Summary Stage 2018: Urethra

Summary Stage 2018

Notes

**Urethra** 8000-8700, 8720-8790, 8940-8960, 8965-8983, 9000, 9050-9111, 9270, 9300-9312, 9340-9363, 9380-9539, 9541 C680: Urethra C680: Prostatic Urethra **Note 1:** **Sources used in the development of this chapter** * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 63 *Urethra*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** **Other Summary Stage Chapters with Urethra sites** * **GIST**: 8935-8936 * **Kaposi Sarcoma**: 9140 * **Mycosis Fungoides**: 9700-9701 * **Soft Tissue**: 8710-8714, 8800-8934, 8963-8964, 8990-8992, 9010-9045, 9120-9138, 9141-9262, 9271-9290, 9320-9330, 9364-9373, 9540, 9542-9582

NAACCR Item

NAACCR #764

SS2018	Description
0	In situ, intraepithelial, noninvasive Papillary * Non-infiltrating or non-invasive papillary transitional cell carcinoma * Non-infiltrating or non-invasive papillary urothelial carcinoma * Papillary transitional cell carcinoma, with inferred description of non-invasion * Papillary urothelial carcinoma, with inferred description of non-invasion Nonpapillary * Carcinoma in situ, NOS * Sessile (flat) (solid) carcinoma in situ * Transitional cell carcinoma in situ * Urothelial carcinoma (in situ, non-infiltrating, non-invasive) Multifocal non-invasive tumors Urethra-Prostatic * Carcinoma in situ involving (WITHOUT stromal invasion) - Periurethral or prostatic ducts - Prostatic urethra
1	Localized only (localized, NOS) * Muscularis invaded * Subepithelial connective tissue (lamina propria, submucosa) invaded
2	Regional by direct extension only * All sites - Bladder neck * Urethra - Corpus cavernosum - Corpus spongiosum - Periurethral muscle (sphincter muscle) - Vagina (anterior, NOS) * Prostatic urethra - Periprostatic fat (beyond prostate capsule) - Prostate (prostatic stroma) - Prostatic ducts
3	Regional lymph node(s) involved only * Iliac (common, external, internal [hypogastric] [obturator], NOS) * Inguinal (superficial [femoral], NOS) * Inguinal, deep (Node of Cloquet or Rosenmuller [highest deep inguinal], NOS) * Pelvic, NOS (including true pelvis) * Perivesical * Presacral * Sacral, NOS * Regional lymph node(s), NOS - Lymph node(s), NOS
4	Regional by BOTH direct extension AND regional lymph node(s) involved * Codes (2) + (3)
7	Distant site(s)/lymph node(s) involved * Distant site(s) (including further contiguous extension) - All sites + Adjacent organ(s), NOS + Bladder wall - Prostatic urethra + Rectal wall * Distant lymph node(s), NOS * Distant metastasis, NOS - Carcinomatosis - Distant metastasis WITH or WITHOUT distant lymph node(s)
9	Unknown if extension or metastasis

(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017 (5) Hansel, D.E., Reuter, V.E., McKiernan, J.M., et al. **Urethra**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017

SS2018	Description
0	In situ, intraepithelial, noninvasive Papillary * Non-infiltrating or non-invasive papillary transitional cell carcinoma * Non-infiltrating or non-invasive papillary urothelial carcinoma * Papillary transitional cell carcinoma, with inferred description of non-invasion * Papillary urothelial carcinoma, with inferred description of non-invasion Nonpapillary * Carcinoma in situ, NOS * Sessile (flat) (solid) carcinoma in situ * Transitional cell carcinoma in situ * Urothelial carcinoma (in situ, non-infiltrating, non-invasive) Multifocal non-invasive tumors Urethra-Prostatic * Carcinoma in situ involving (WITHOUT stromal invasion) - Periurethral or prostatic ducts - Prostatic urethra
1	Localized only (localized, NOS) * Muscularis invaded * Subepithelial connective tissue (lamina propria, submucosa) invaded
2	Regional by direct extension only * All sites - Bladder neck * Urethra - Corpus cavernosum - Corpus spongiosum - Periurethral muscle (sphincter muscle) - Vagina (anterior, NOS) * Prostatic urethra - Periprostatic fat (beyond prostate capsule) - Prostate (prostatic stroma) - Prostatic ducts
3	Regional lymph node(s) involved only * Iliac (common, external, internal [hypogastric] [obturator], NOS) * Inguinal (superficial [femoral], NOS) * Inguinal, deep (Node of Cloquet or Rosenmuller [highest deep inguinal], NOS) * Pelvic, NOS (including true pelvis) * Perivesical * Presacral * Sacral, NOS * Regional lymph node(s), NOS - Lymph node(s), NOS
4	Regional by BOTH direct extension AND regional lymph node(s) involved * Codes (2) + (3)
7	Distant site(s)/lymph node(s) involved * Distant site(s) (including further contiguous extension) - All sites + Adjacent organ(s), NOS + Bladder wall - Prostatic urethra + Rectal wall * Distant lymph node(s), NOS * Distant metastasis, NOS - Carcinomatosis - Distant metastasis WITH or WITHOUT distant lymph node(s)
9	Unknown if extension or metastasis